--- title: Blog - Launch and Market Access trends in pharma | TRiBECA Knowledge | London description: Keep up to date with the latest launch, market access and tender management trends in the pharmaceutical and biotech sector. --- ## Featured Post ### [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-author.png) Andre Moa - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-date.png) 21 Jan 2025 - ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-length.png) 21 minute read Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good. [Read more](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) ## Latest posts ### [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) FDA and EMA approvals are down in 2025 as major US and EU reforms shift pricing and access. Explore the trends shaping drug launches and market entry. [Read more](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) ### [Driving launch excellence with agile transformation](https://www.tribecaknowledge.com/blog/driving-launch-excellence-with-agile-transformation) Driving launch excellence through agile transformation — how biopharma teams can reduce uncertainty, enhance learning, and accelerate successful launches. [Read more](https://www.tribecaknowledge.com/blog/driving-launch-excellence-with-agile-transformation) ### [Launch Readiness 2025: What this year holds in store for pharma product launches](https://www.tribecaknowledge.com/blog/launch-readiness-2025-what-this-year-holds-in-store-for-pharma-product-launches) Pharma innovation stays strong, but market access barriers persist. Discover key trends and strategies in our Launch Readiness 2025 report. [Read more](https://www.tribecaknowledge.com/blog/launch-readiness-2025-what-this-year-holds-in-store-for-pharma-product-launches) ### [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) Discover 6 key pharma trends for 2025, including Trump's policies, AI-driven innovations, market access challenges, and evolving global regulations shaping the industry. [Read more](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) ### [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) Discover key FDA & EMA drug approvals of 2024, breakthrough innovations, and market trends. Explore what these approvals reveal about the pharma industry's future. [Read more](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) ### [Market Access 2025: Navigating the emerging HTA and drug reimbursement challenges](https://www.tribecaknowledge.com/blog/market-access-2025-new-report-on-navigating-the-emerging-hta-and-drug-reimbursement-challenges) Discover insights from 'Market Access 2025' on overcoming HTA and drug reimbursement challenges. Learn strategies to navigate evolving market access hurdles. [Read more](https://www.tribecaknowledge.com/blog/market-access-2025-new-report-on-navigating-the-emerging-hta-and-drug-reimbursement-challenges) ### [Launch Readiness 2024: A fresh look at key trends affecting pharma product launches](https://www.tribecaknowledge.com/blog/launch-readiness-2024-a-fresh-look-at-key-trends-affecting-pharma-product-launches) Revitalized US approvals and thriving innovation are positive signs for new medicines this year. However, our Launch Readiness 2024 guide shows that cost and value remain critical to launch success. [Read more](https://www.tribecaknowledge.com/blog/launch-readiness-2024-a-fresh-look-at-key-trends-affecting-pharma-product-launches) ### [3 Pharma Trends for 2024: All about market access](https://www.tribecaknowledge.com/blog/3-pharma-trends-for-2024-all-about-market-access) Discover the key HTA and market access challenges in the pharma industry for 2024 and how companies can navigate them. Learn about the impact of EU's pharma review and price pressures in Germany and Japan, and get ready for EU's HTAR. [Read more](https://www.tribecaknowledge.com/blog/3-pharma-trends-for-2024-all-about-market-access) ### [2023 New Drug Approvals: Review of New FDA and EMA Marketing Authorisations](https://www.tribecaknowledge.com/blog/2023-new-drug-approvals-review-of-new-fda-and-ema-marketing-authorisations) 2023 New Drug Approvals: Review of New FDA and EMA Marketing Authorisations [Read more](https://www.tribecaknowledge.com/blog/2023-new-drug-approvals-review-of-new-fda-and-ema-marketing-authorisations) ### [Market Access 2023: New Report on key challenges in HTA and reimbursement](https://www.tribecaknowledge.com/blog/market-access-2023-new-report-on-key-challenges-in-hta-and-reimbursement) As market access barriers proliferate, digitally enabled alignment is key to optimising new drug uptake. [Read more](https://www.tribecaknowledge.com/blog/market-access-2023-new-report-on-key-challenges-in-hta-and-reimbursement) ### [Launch Readiness 2023: Key trends impacting pharma product launches](https://www.tribecaknowledge.com/blog/launch-readiness-2023-a-new-look-at-key-trends-in-the-pharma-launch-environment) Our Launch Readiness 2023 report examines the prospects and challenges for new medicines entering the market in the shadow of COVID-19. [Read more](https://www.tribecaknowledge.com/blog/launch-readiness-2023-a-new-look-at-key-trends-in-the-pharma-launch-environment) ### [5 Pharma Trends for 2023: Challenges and opportunities in the post-COVID landscape](https://www.tribecaknowledge.com/blog/5-pharma-trends-for-2023-challenges-and-opportunities-in-the-post-covid-landscape) Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good. [Read more](https://www.tribecaknowledge.com/blog/5-pharma-trends-for-2023-challenges-and-opportunities-in-the-post-covid-landscape) ### Recent Posts - [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) - [Driving launch excellence with agile transformation](https://www.tribecaknowledge.com/blog/driving-launch-excellence-with-agile-transformation) - [Launch Readiness 2025: What this year holds in store for pharma product launches](https://www.tribecaknowledge.com/blog/launch-readiness-2025-what-this-year-holds-in-store-for-pharma-product-launches) - [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) ### Most Popular Posts - [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends) - [What Pfizer’s digital transformation strategy can teach us about making pharma more agile and effective](https://www.tribecaknowledge.com/blog/what-pfizers-digital-transformation-strategy-can-teach-us-about-making-pharma-more-agile-and-effective) - [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends) - [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges) - [Market Access 2025: Navigating the emerging HTA and drug reimbursement challenges](https://www.tribecaknowledge.com/blog/market-access-2025-new-report-on-navigating-the-emerging-hta-and-drug-reimbursement-challenges) ### Categories - [launch readiness](https://www.tribecaknowledge.com/blog/topic/launch-readiness) - [Market access](https://www.tribecaknowledge.com/blog/topic/market-access) - [Pharma trends](https://www.tribecaknowledge.com/blog/topic/pharma-trends) - [Pharma launch planning](https://www.tribecaknowledge.com/blog/topic/pharma-launch-planning) - [launch plan](https://www.tribecaknowledge.com/blog/topic/launch-plan) - [launch readiness framework](https://www.tribecaknowledge.com/blog/topic/launch-readiness-framework) - [launch effectiveness](https://www.tribecaknowledge.com/blog/topic/launch-effectiveness) - [launch strategy](https://www.tribecaknowledge.com/blog/topic/launch-strategy) - [Tender Management](https://www.tribecaknowledge.com/blog/topic/tender-management) #### Get our latest posts in your inbox TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.